中国自1978年改革开放以来，高昂的医疗支出和虚高的药价一直是影响民生的重大问题。 2018年爆火的内地电影《我不是药神》，就反映了许多癌症患者面临的困境：单价近万元的标靶药物让他们望而却步。有鉴于此，中国政府近年来对药价管理机制进行革命性的改革，取得了巨大成效。
14 Jun 2023
教学人员
Prof. Wen ZHOU
管理及商业策略
Associate Professor
Associate Director, Asia Case Research Centre
3917 5665
KK 1225
Academic & Professional Qualification
- PhD in Economics, Duke University
- MA in Economics, Peking University
- BSc in Biology, University of Science & Technology of China
Biography
Dr. Wen Zhou is an Associate Professor in the group of Management and Strategy, HKU Business School. He received BS in biology from the University of Science and Technology of China, MA in economics from Peking University and PhD in economics from Duke University. He joined the University of Hong Kong in 2007 after working at the Hong Kong University of Science and Technology for several years.
Teaching
Dr. Zhou teaches Managerial Economics for MBA, IMBA, and EMBA.
Research Interest
Dr. Zhou is an economist working in the field of industrial organization. His research focuses on endogenous market structure in the presence of mergers, innovation, and international trade. He has also studied business strategies such as pricing and advertising.
Selected Publications
- “Creating a merger option to strategically prevent a merger among suppliers or customers”, with Lezhen Wu, Dingwei Gu and Zhiyong Yao, Naval Research Logistics, 2023, Forthcoming. https://doi.org/10.1002/nav.22148
- “Sequential Mergers Under Incomplete Information”, with Jiajia Cong, Journal of Economics and Management Strategy, 2023, Forthcoming. https://doi.org/10.1111/jems.12549
- “Proportional Fee vs. Unit Fee: Competition, Welfare, and Incentives”, with Dingwei Gu and Zhiyong Yao, Journal of Industrial Economics, 2022, Vol. 70, No. 4, pp. 999-1032. https://doi.org/10.1111/joie.12279
- “Inflexible Repositioning: Commitment in Competition and Uncertainty”, with Jiajia Cong, Management Science, 2020, Vol. 66, No. 9, pp. 4207-4225. https://doi.org/10.1287/mnsc.2019.3383
- “Vertical Integration and Disruptive Cross-market R&D”, with Ping Lin and Tianle Zhang, Journal of Economics and Management Strategy, 2020, Vol. 29, No. 1, pp. 51-73. https://doi.org/10.1111/jems.12328
- “When is Upstream Collusion Profitable?”, with Dingwei Gu, Zhiyong Yao, and Rangrang Bai, RAND Journal of Economics, 2019, Vol. 50, No. 2, pp. 326-341. https://doi.org/10.1111/1756-2171.12271
- “Entry, Reputation and Intellectual Property Rights Enforcement”, with Jiahua Che and Larry Qiu, Canadian Journal of Economics, 2014, Vol. 47, No. 4, pp. 1256-1281. https://doi.org/10.1111/caje.12104
- “Multiproduct Firms and Scope Adjustment in Globalization”, with Larry Qiu, Journal of International Economics, 2013, Vol. 91, No. 1, pp. 142-153. https://doi.org/10.1016/j.jinteco.2013.04.006
- “The Effects of Competition on the R&D Portfolios of Multiproduct Firms”, with Ping Lin, International Journal of Industrial Organization, 2013, Vol. 31, No. 1, pp. 83-91. https://doi.org/10.1016/j.ijindorg.2012.11.003
- “Endogenous Horizontal Mergers under Cost Uncertainty”, International Journal of Industrial Organization, 2008, Vol. 26, No. 4, pp. 903-912. https://doi.org/10.1016/j.ijindorg.2006.10.010
- “Large is Beautiful: Horizontal Mergers for Better Exploitation of Production Shocks”, Journal of Industrial Economics, 2008, Vol. 56, No. 1, pp. 68-93. https://doi.org/10.1111/j.1467-6451.2008.00333.x
- “Merger Waves: A Model of Endogenous Mergers”, with Larry Qiu, RAND Journal of Economics, 2007, Vol. 38, No. 1, pp. 214-226. https://doi.org/10.1111/j.1756-2171.2007.tb00052.x
- “International Mergers: Incentives and Welfare”, with Larry Qiu, Journal of International Economics, 2006, Vol. 68, No. 1, pp. 38-58. https://doi.org/10.1016/j.jinteco.2004.12.005
- “The Choice of Commercial Breaks in Television Programs: The Number, Length, and Timing”, Journal of Industrial Economics, 2004, Vol. 52, No. 3, pp. 315-326. https://doi.org/10.1111/j.0022-1821.2004.00228.x
Recent Publications
14Jun
14Jun
中国自1978年改革开放以来，高昂的医疗支出和虚高的药价一直是影响民生的重大问题。 2018年爆火的内地电影《我不是药神》，就反映了许多癌症患者面临的困境：单价近万元的标靶药物让他们望而却步。有鉴于此，中国政府近年来对药价管理机制进行革命性的改革，取得了巨大成效。
14 Jun 2023
管理及商业策略
19Oct
西区海底隧道（西隧）专营权明年8月届满，政府计划继接收西隧后，在三条过海隧道实施「挤塞征费」。这个方案向立法会提出后，社会上出现一些反对意见。其实，按照挤塞程度分段收费，是各种方案中比较科学可行的一种，也是世界各大城市公共交通政策的共同趋势。
19 Oct 2022
教学人员
19Oct
西区海底隧道（西隧）专营权明年8月届满，政府计划继接收西隧后，在三条过海隧道实施「挤塞征费」。这个方案向立法会提出后，社会上出现一些反对意见。其实，按照挤塞程度分段收费，是各种方案中比较科学可行的一种，也是世界各大城市公共交通政策的共同趋势。
19 Oct 2022
管理及商业策略
21Sep
近年美国民意两极化，许多社会重大问题如枪械管制、堕胎等难以化解。民众的分歧，本该以少数服从多数的原则，在国会通过立法来解决，但这一原则常常无法奏效。少数派的拿手绝活是「拉布」，亦即通过长时间发言、讨论，阻止对某项法案投票以至法案的通过。从古罗马到当今各国议会，包括香港特区立法会的不同党派，都使用过这种手段。美国国会参众两院则只有参议院可以拉布，这自然成为法案通过的重要关卡。
21 Sep 2022
教学人员
21Sep
近年美国民意两极化，许多社会重大问题如枪械管制、堕胎等难以化解。民众的分歧，本该以少数服从多数的原则，在国会通过立法来解决，但这一原则常常无法奏效。少数派的拿手绝活是「拉布」，亦即通过长时间发言、讨论，阻止对某项法案投票以至法案的通过。从古罗马到当今各国议会，包括香港特区立法会的不同党派，都使用过这种手段。美国国会参众两院则只有参议院可以拉布，这自然成为法案通过的重要关卡。
21 Sep 2022
管理及商业策略
29Jun
男子组合MIRROR的演唱会即将开始，全城早已掀起抢票潮，粉丝却苦于一票难求。即使另加两场特别场，采用实名制售票，依然无法阻止黄牛党疯狂炒票。公开发售的门票瞬间售罄，有本地传媒报道，二手市场上的黄牛票竟被炒到40多万元，粉丝们自然叫苦连天。
29 Jun 2022
教学人员
29Jun
男子组合MIRROR的演唱会即将开始，全城早已掀起抢票潮，粉丝却苦于一票难求。即使另加两场特别场，采用实名制售票，依然无法阻止黄牛党疯狂炒票。公开发售的门票瞬间售罄，有本地传媒报道，二手市场上的黄牛票竟被炒到40多万元，粉丝们自然叫苦连天。
29 Jun 2022
市场学